TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Echo Therapeutics Inc (NASDAQ:ECTE) Investor Investigation Over Potential Securities Laws Violations Announced

  • If you purchased shares of Echo Therapeutics Inc (NASDAQ:ECTE), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Echo Therapeutics Inc
Security
NASDAQ: ECTE

Summary

May 20, 2016 (Shareholders Foundation) - An investigation on behalf of investors of Echo Therapeutics Inc (NASDAQ:ECTE) shares over potential securities laws violations in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Echo Therapeutics Inc (NASDAQ:ECTE) concerning whether a series of statements regarding Echo Therapeutics business, its prospects and its operations were materially false and misleading at the time they were made.

Iselin, NJ based Echo Therapeutics, Inc. is engaged in developing a non-invasive, wireless continuous glucose monitoring system with use in the wearable-health consumer market and the diabetes outpatient market. Echo Therapeutics Inc reported that its annual Net Loss increased from $14.96 million in 2014 to $22.20 million in 2015.

Shares of Echo Therapeutics Inc (NASDAQ:ECTE) closed at May 17, 2016, at $1.60 per share.

Start Monitoring Your Investments